These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 11362607)
1. Hoffmann-LaRoche announces international compassionate treatment program for saquinavir. J Int Assoc Physicians AIDS Care; 1995 Jun; 1(5):32-4. PubMed ID: 11362607 [TBL] [Abstract][Full Text] [Related]
2. Protease inhibitor: Roche lottery deadline July 21. AIDS Treat News; 1995 Jul; (no 226):4-5. PubMed ID: 11362614 [TBL] [Abstract][Full Text] [Related]
3. Lottery opens 2,000 slots for protease trial. AIDS Alert; 1995 Nov; 10(11):144. PubMed ID: 11362929 [TBL] [Abstract][Full Text] [Related]
4. European hurdles for saquinavir. J Int Assoc Physicians AIDS Care; 1995 Dec; 1(11):44. PubMed ID: 11363099 [TBL] [Abstract][Full Text] [Related]
5. Saquinavir: newest weapon in the antiviral arsenal. MacDougall DS J Int Assoc Physicians AIDS Care; 1996 Feb; 2(2):25-31. PubMed ID: 11363336 [TBL] [Abstract][Full Text] [Related]
6. FDA antiviral advisory hearings on lamivudine (Epivir, 3TC), saquinavir (Invirase), stavudine (Zerit, d4T), November 6-8. Food and Drug Administration. AIDS Treat News; 1995 Oct; (no 233):4-5. PubMed ID: 11363038 [TBL] [Abstract][Full Text] [Related]
7. Protease inhibitor trials moving to next phase. AIDS Alert; 1995 Aug; 10(8):100-1. PubMed ID: 11362675 [TBL] [Abstract][Full Text] [Related]
9. Saquinavir (Invirase): first protease inhibitor approved--reimbursement, information hotline numbers. James JS AIDS Treat News; 1995 Dec; (no 237):1-2. PubMed ID: 11363073 [TBL] [Abstract][Full Text] [Related]
10. Potent new AIDS drugs underscore promise of combination therapy. AIDS Alert; 1996 Jan; 11(1):1-4. PubMed ID: 11363225 [TBL] [Abstract][Full Text] [Related]
11. Europe out of step with the US. Alcorn K J Int Assoc Physicians AIDS Care; 1996 Jan; 2(1):33-4. PubMed ID: 11363328 [TBL] [Abstract][Full Text] [Related]